Clinical Trial Update: Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjuvant Sintilimab for locally advanced esophageal squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: RECRUITING